Patent · US Active

Aminoacyl tRNA synthetases for modulating inflammation

US9127268B2 · kind B2 · utility

13Cited by

42References

49Claims

0Family size

Assignee

aTyr Pharma, Inc. · US

Inventors

Jeffry D. Watkins · Encinitas, US
Alain P. Vasserot · South San Francisco, US
Leslie Ann Greene · San Diego, US
Ryan Andrew Adams · San Diego, US
Kristi Helen Piehl · San Diego, US
Fei Hong · San Diego, US
Kyle P. Chiang · Irvine, US
Wei Zhang · Brecksville, US
Alina He · San Francisco, US

Key dates

Filing date	Dec 10, 2010
Grant date	Sep 8, 2015
Priority date	—
Expiry date	Sep 5, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y601/01021
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Inflammatory and other cellular response-modulating compositions are provided comprising aminoacyl-tRNA synthetase polypeptides, including active fragments and/or variants thereof. Also provided are methods of using such compositions in the treatment of conditions that benefit from the modulation of inflammation, such as inflammatory diseases or conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.